Location History:
- München, DE (2014 - 2016)
- Munich, DE (2017 - 2019)
Company Filing History:
3 out of 175 
2 out of 267 
2 out of 17 
Years Active: 2014-2019
Title: Innovator Spotlight: Christoph Reisinger
Introduction
Christoph Reisinger is a notable inventor based in Munich, Germany, recognized for his contributions to biotechnology. With an impressive portfolio featuring seven patents, Reisinger's work is at the forefront of advancements in enzyme engineering and synthetic biology.
Latest Patents
Reisinger's latest innovations include two significant patents. The first is related to "Polypeptides having xylanase activity with a high conversion rate of xylose-containing polysaccharides." This invention provides novel polypeptides with xylanase activity, detailing the nucleic acid sequences that encode these polypeptides, along with vectors and transformed host cells. Additionally, a comprehensive method for producing these polypeptides and a composition featuring these inventive polypeptides is included.
His second latest patent, titled "Oligonucleotide sequence for use in pathway engineering," introduces a novel artificial oligonucleotide sequence designed to initiate gene transcription under varying conditions at high levels. This invention encompasses a recombinant DNA fragment containing the artificial sequence, an expression plasmid, and a host cell transformed with the recombinant DNA fragment.
Career Highlights
Throughout his career, Christoph Reisinger has worked with prominent companies, including Clariant Produkte (Deutschland) GmbH and Clariant International Ltd. His expertise in biotechnology has allowed him to contribute significantly to the fields of enzyme production and pathway engineering.
Collaborations
Reisinger has collaborated with several colleagues in his field, including Isabel Unterstrasser and Michael Kraus. Their partnerships reflect a commitment to innovation and shared expertise in advancing scientific knowledge.
Conclusion
Christoph Reisinger's innovative spirit and dedication to biotechnology have positioned him as a leading inventor in the industry. With his extensive patent portfolio, he continues to influence the future of enzyme engineering and synthetic biology, paving the way for new technological advancements.